Rahnella aquatilis bacteremia in a patient with relapsed acute lymphoblastic leukemia

Scand J Infect Dis. 2001;33(6):471-3. doi: 10.1080/00365540152029972.

Abstract

Rahnella aquatilis infections are rare. We report the case of a 46-y-old African-American male with relapsed acute lymphoblastic leukemia who had R. aquatilis bacteremia after beginning reinduction chemotherapy. He was treated for 4 weeks with piperacillin-tazobactam and gentamicin. He recovered from the infection and had an allogenic bone marrow transplant a month later.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Bacteremia / drug therapy
  • Bacteremia / microbiology*
  • Bone Marrow Transplantation
  • Burkitt Lymphoma / therapy*
  • Drug Therapy, Combination / therapeutic use
  • Gram-Negative Bacterial Infections / drug therapy
  • Gram-Negative Bacterial Infections / microbiology*
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects
  • Male
  • Middle Aged
  • Penicillanic Acid / analogs & derivatives
  • Penicillanic Acid / therapeutic use
  • Piperacillin / therapeutic use
  • Piperacillin, Tazobactam Drug Combination
  • Rahnella*

Substances

  • Immunosuppressive Agents
  • Piperacillin, Tazobactam Drug Combination
  • Penicillanic Acid
  • Piperacillin